InsidersTradesSigma
Total declarations
Company
▲ Purchases (7 ops.)
▼ Sales (0 ops.)
Browse the detailed record of transactions filed by christophe calice, Director. Director active across 1 companies, notably AFYREN. Cumulatively, 7 filings have been published. Total volume traded: €1.7m. The latest transaction was filed on 20 April 2023 — Acquisition. Regulator: AMF. All data is accessible without signup.
Declarations7 total
€4,1411,000 shares@ €4.14080.0073% mcap7.6% of flow
ActionEuronext Growth Paris
2023DD895806·
Ideal exit: 15 Jan 2024 (T+270)
€12,4402,800 shares@ €4.44270.022% mcap22.9% of flow
ActionEuronext Paris
2023DD892742·
Ideal exit: 26 Dec 2023 (T+270)
€5,6901,000 shares@ €5.690.010% mcap10.5% of flow
ActionEuronext Growth Paris
2022DD866486·
Ideal exit: 10 Jul 2023 (T+270)
€6,0641,000 shares@ €6.0640.011% mcap11.2% of flow
ActionEuronext Growth Paris
2022DD864779·
Ideal exit: 27 Jun 2023 (T+270)
€6,098800 shares@ €7.62290.011% mcap11.2% of flow
ActionEuronext Growth Paris
2022DD859102·
Ideal exit: 29 May 2023 (T+270)
€19,9422,695 shares@ €7.39950.035% mcap36.7% of flow
ActionEuronext Growth Paris
2022DD856567·
Ideal exit: 4 Jul 2022 (T+270)
€2m283,493 shares@ €5.882.94% mcap100.0% of flow
ActionEuronext Growth Paris
2022DD854937·
Ideal exit: 21 Apr 2023 (T+270)
7 of 7 declarations
About christophe calice
Christophe Calice is a French business executive primarily associated with AFYREN, the listed green-chemistry company developing low-carbon, bio-based ingredients. At AFYREN, he serves in a governance capacity as a board director, representing AFY Partners. Company governance disclosures also indicate that he chairs the remuneration committee, placing him in a key oversight role within the board structure. His professional profile appears closely linked to strategic investment, corporate structuring, and support for innovative growth companies. AFYREN’s annual financial report identifies him as manager of AFY Partners, as well as manager of Ecilac Capital and XL2C Invest. These positions suggest a strong background in investment governance, capital allocation, and the supervision of entrepreneurial assets, with a particular focus on scaling businesses and supporting long-term value creation. Within AFYREN, his role has been relevant during a decisive phase in the company’s development: industrial scale-up, financing execution, and commercial expansion. AFYREN raised more than €70 million in 2019, completed an IPO on Euronext Growth Paris in 2021 that raised nearly €70 million more, and then advanced toward industrial production with the construction of its first factory. The company has also continued to announce commercial progress and additional financing for AFYREN NEOXY, its industrial subsidiary. In this context, Christophe Calice contributes to a governance framework focused on strategic discipline, financial oversight, and sustainable growth. His board-level position is consistent with experience suited to technology-driven and industrial companies: understanding industrialization challenges, evaluating growth risk, balancing innovation with profitability, and supporting relations with shareholders and institutional investors. For a company such as AFYREN, active in the bioeconomy and in replacing petro-sourced inputs with renewable alternatives, that kind of governance profile is particularly valuable for reinforcing execution, credibility, and long-term strategic ambition.
